Robin L. Washington
2010
In 2010, Robin L. Washington earned a total compensation of $3.3M as Senior Vice President and Chief Financial Officer at Gilead Sciences, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $453,113 |
|---|---|
| Option Awards | $727,824 |
| Salary | $559,339 |
| Stock Awards | $1,560,750 |
| Other | $5,000 |
| Total | $3,306,026 |
Washington received $1.6M in stock awards, accounting for 47% of the total pay in 2010.
Washington also received $453.1K in non-equity incentive plan, $727.8K in option awards, $559.3K in salary and $5K in other compensation.
Rankings
In 2010, Robin L. Washington's compensation ranked 1,766th out of 10,439 executives tracked by ExecPay. In other words, Washington earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,766 out of 10,439 | 83rd |
Division Manufacturing | 627 out of 3,837 | 84th |
Major group Chemicals And Allied Products | 118 out of 925 | 87th |
Industry group Drugs | 67 out of 684 | 90th |
Industry Biological Products, Except Diagnostic Substances | 11 out of 147 | 93rd |
Source: SEC filing on March 19, 2013.
Washington's colleagues
We found five more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2010.
2010
John Martin
Gilead Sciences
Chief Executive Officer
2010
John Milligan
Gilead Sciences
Chief Operating Officer
2010
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2010
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2010
Norbert Bischofberger
Gilead Sciences